Investigating how social factors affect COVID-19 testing and vaccination in Latinx adults
Official title: A Multi-site Investigation of Social Determinants of Health and SARS-CoV-2 Testing and Vaccination Outcomes among Diverse US Latinx Adults
Funded at University of Oregon · NIH-10933024 · Data updated 2026-11-12
This study looks at how things like discrimination, money, and healthcare access affect COVID-19 testing and vaccination among Latinx adults in the U.S., aiming to better understand their unique experiences to improve health strategies for everyone.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oregon NIH-funded |
| Lab location | 1 site (Eugene, United States) |
| Project start | September 21, 2023 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $223,500 |
| NIH project number | 5R21MD019396-02 |
| Project ID | NIH-10933024 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Latinx adults aged 21 and older who have experienced barriers to COVID-19 testing and vaccination.
✕Less likely to help
Patients who do not identify as Latinx or those under 21 years old may not receive direct benefits from this research.
What this research studies
This research examines the impact of social determinants of health on COVID-19 testing and vaccination outcomes among diverse Latinx adults in the United States. By analyzing data from over 31,000 participants across various locations, the study aims to uncover how factors like discrimination, economic status, and access to healthcare influence health outcomes during the pandemic. The approach focuses on understanding the unique experiences of Latinx individuals, rather than treating them as a single group, to develop more effective public health strategies.
Why it matters
Potential benefit: If successful, this research could lead to improved COVID-19 testing and vaccination strategies tailored specifically for Latinx communities, ultimately enhancing health equity.
How similar studies have gone: Previous research has shown that addressing social determinants of health can significantly improve health outcomes in marginalized communities, suggesting that this approach may yield valuable insights.
Where this research is happening
-
University of Oregon
Eugene, United States Active
Researchers
- Principal investigator: De Anda, Stephanie — University of Oregon
- Study coordinator: De Anda, Stephanie
Related research
Other NIH-funded projects on the same topics.
-
How different COVID-19 vaccines shape immune responses
This project compares immune reactions after mRNA and adenoviral COVID-19 vaccines to learn how long protection lasts and why some people get breakthrough infections or side effects.
-
How our immune system keeps a memory of vaccines and infections over time
A long-term study to understand how T cells remember SARS-CoV-2 vaccines and infections, and how this compares with common cold coronaviruses.
-
How lung memory T cells protect you after COVID-19 infection or vaccination
Researchers want to see if immune cells that stay in the lungs after COVID-19 infection or vaccination help protect people from future severe lung illness.
-
COVID-19 vaccine responses in kidney transplant patients taking mycophenolate
This project looks at how the anti-rejection drug mycophenolate affects COVID-19 vaccine protection in people with kidney transplants.
-
Understanding how SARS-CoV-2 vaccines affect immune responses
This study is looking at how well the COVID-19 vaccine and natural infection help your immune system fight the virus, by checking the types of antibodies in your blood and how long they last, so we can better understand protection against COVID-19.
-
Investigating immune responses to COVID-19 vaccination in children with multiple sclerosis on immunotherapy
This study is looking at how different treatments for multiple sclerosis affect how well kids respond to COVID-19 vaccines, so we can better understand how to protect them.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.